Joshua T. Brumm, CEO: Crescent Biopharma CBIO Sell · Filed 06/23

Trade details

Type: Insider sale
Amount: $761,066.95
Shares · price: 42,305 sh · $17.99 a share
Held after: 281,212 sh
Stock: Crescent Biopharma CBIO
Person: Joshua T. BrummCEO
Trade date: 26/06/22
Filed: 26/06/23
Days to filing: 1 days

Sold 13.1% of holdings

Share of holding sold: 13.1%

Crescent Biopharma trades, last 26 weeks

What else happened in Crescent Biopharma around then

Filed or reported within 30 days of the trade day · 05/23~07/22

Joshua T. Brumm's recent trades

Joshua T. BrummCEO
Planned sale10b5-1 planCrescent Biopharma
Planned sale10b5-1 plan
Crescent Biopharma
CBIO
$154.8K
9,013 sh
$154.8K
Filed 09/17
Traded 09/18
Joshua T. BrummCEO
Planned sale10b5-1 planCrescent Biopharma
Planned sale10b5-1 plan
Crescent Biopharma
CBIO
$33.3K
1,771 sh
$33.3K
Filed 09/16
Traded 09/16
Joshua T. BrummCEO & President
Sell10b5-1 planDyne Therapeutics
Sell10b5-1 plan
Dyne Therapeutics
DYN
$5.1M
202,238 sh
$5.1M
Filed 24/03/12
Traded 24/03/08
Joshua T. BrummCEO & President
Sell10b5-1 planDyne Therapeutics
Sell10b5-1 plan
Dyne Therapeutics
DYN
$4.3M
160,670 sh
$4.3M
Filed 24/03/12
Traded 24/03/08
Joshua T. BrummCEO & President
Sell10b5-1 planDyne Therapeutics
Sell10b5-1 plan
Dyne Therapeutics
DYN
$1M
40,072 sh
$1M
Filed 24/03/12
Traded 24/03/11

Joshua T. Brumm, CEO — sold $761.1K of Crescent Biopharma CBIO · 13.1% of holdings · 10b5-1 plan | Whalegun